KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $103.0 million.

  • Quest Diagnostics' Depreciation and Depletion rose 1075.27% to $103.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.0 million, marking a year-over-year increase of 1600.0%. This contributed to the annual value of $366.0 million for FY2024, which is 1057.4% up from last year.
  • Quest Diagnostics' Depreciation and Depletion amounted to $103.0 million in Q3 2025, which was up 1075.27% from $104.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Depreciation and Depletion registered a high of $104.0 million during Q2 2025, and its lowest value of $74.0 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $82.0 million (2023), whereas its average is $85.6 million.
  • Per our database at Business Quant, Quest Diagnostics' Depreciation and Depletion skyrocketed by 2333.33% in 2021 and then tumbled by 375.0% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Depreciation and Depletion stood at $80.0 million in 2021, then decreased by 3.75% to $77.0 million in 2022, then increased by 6.49% to $82.0 million in 2023, then rose by 19.51% to $98.0 million in 2024, then rose by 5.1% to $103.0 million in 2025.
  • Its Depreciation and Depletion was $103.0 million in Q3 2025, compared to $104.0 million in Q2 2025 and $101.0 million in Q1 2025.